Literature DB >> 26201923

Roles of alcohol drinking pattern in fatty liver in Japanese women.

Akio Moriya1, Yoshiaki Iwasaki2,3, Souhei Ohguchi4, Eizo Kayashima5, Tadahiko Mitsumune6, Fusao Ikeda7, Masaharu Ando8, Kazuhide Yamamoto9.   

Abstract

PURPOSE: Several studies have reported an inverse association between moderate alcohol consumption and prevalence of fatty liver (FL) in men. We aimed to clarify this association in women.
METHODS: We collected health checkup data from 4,921 Japanese women without concurrent liver disease (mean age 46.4 years) and performed a cross-sectional study to evaluate the influence of alcohol drinking patterns (frequency and amount) on the prevalence of FL as assessed by ultrasonography.
RESULTS: Alcohol consumption was reported in 30.8 % of participants, and FL was observed in 13.8 % (15.5 % nondrinkers, 10.1 % drinkers). Alcohol consumption was inversely associated with FL prevalence [adjusted odds ratio (AOR) 0.79, 95 % confidence interval (CI) 0.63-0.98]. In analyses stratified by drinking frequency and/or amount of alcohol consumed, the risk of FL decreased for the following categories: 0.1-19.9 g/drinking day (AOR 0.61, 95 % CI 0.44-0.83) and 0.1-69.9 g/week (AOR 0.74, 95 % CI 0.55-0.98). The amount of alcohol consumed directly correlated with the prevalence of FL in daily drinkers (p < 0.05), whereas there was no correlation between the frequency of alcohol consumption and FL prevalence. Alanine aminotransferase levels were significantly lower for the following categories: 0.1-19.9 g/drinking day for 1-3 days a week (p = 0.016) and 0.1-69.9 g within 1-3 drinking days a week (p = 0.004).
CONCLUSIONS: Minimal alcohol consumption appears to have protective effects against nonalcoholic FL disease in women, although an increase in the amount of alcohol consumed appears to nullify the protective effect.

Entities:  

Keywords:  Alcohol consumption; Drinking frequency; Metabolic syndrome; Nonalcoholic fatty liver disease; Ultrasonography

Year:  2013        PMID: 26201923     DOI: 10.1007/s12072-013-9449-9

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  38 in total

1.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

Authors:  J B Dixon; P S Bhathal; P E O'Brien
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

2.  Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group.

Authors:  S Bellentani; G Saccoccio; G Costa; C Tiribelli; F Manenti; M Sodde; L Saveria Crocè; F Sasso; G Pozzato; G Cristianini; G Brandi
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

Review 3.  Nonalcoholic fatty liver disease and the metabolic syndrome.

Authors:  Giulio Marchesini; Rebecca Marzocchi; Federica Agostini; Elisabetta Bugianesi
Journal:  Curr Opin Lipidol       Date:  2005-08       Impact factor: 4.776

4.  Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study.

Authors:  Bette Liu; Angela Balkwill; Gillian Reeves; Valerie Beral
Journal:  BMJ       Date:  2010-03-11

5.  Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men.

Authors:  Kenneth J Mukamal; Katherine M Conigrave; Murray A Mittleman; Carlos A Camargo; Meir J Stampfer; Walter C Willett; Eric B Rimm
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

6.  Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells.

Authors:  Lars P Bechmann; Denis Zahn; Robert K Gieseler; Christian D Fingas; Guido Marquitan; Christoph Jochum; Guido Gerken; Scott L Friedman; Ali Canbay
Journal:  Hepatol Res       Date:  2009-01-14       Impact factor: 4.288

Review 7.  Non-alcoholic fatty liver disease in the metabolic syndrome.

Authors:  Giuseppe Palasciano; Antonio Moschetta; Vincenzo O Palmieri; Ignazio Grattagliano; Gianluca Iacobellis; Piero Portincasa
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

8.  Resveratrol alleviates alcoholic fatty liver in mice.

Authors:  Joanne M Ajmo; Xiaomei Liang; Christopher Q Rogers; Brandi Pennock; Min You
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-28       Impact factor: 4.052

9.  Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men.

Authors:  E B Rimm; J Chan; M J Stampfer; G A Colditz; W C Willett
Journal:  BMJ       Date:  1995-03-04

10.  Acute alcohol consumption improves insulin action without affecting insulin secretion in type 2 diabetic subjects.

Authors:  Angelo Avogaro; Richard M Watanabe; Alessandra Dall'Arche; Saula Vigili De Kreutzenberg; Antonio Tiengo; Giovanni Pacini
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

View more
  5 in total

1.  Moderate alcohol intake induces thermogenic brown/beige adipocyte formation via elevating retinoic acid signaling.

Authors:  Bo Wang; Zhixiu Wang; Jeanene M de Avila; Mei-Jun Zhu; Faya Zhang; Noe Alberto Gomez; Liang Zhao; Qiyu Tian; Junxing Zhao; Joseph Maricelli; Hui Zhang; Buel D Rodgers; Min Du
Journal:  FASEB J       Date:  2017-07-05       Impact factor: 5.191

2.  Alcohol consumption and risk of fatty liver disease: a meta-analysis.

Authors:  Guoli Cao; Tingzhuang Yi; Qianqian Liu; Min Wang; Shaohui Tang
Journal:  PeerJ       Date:  2016-10-27       Impact factor: 2.984

Review 3.  Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?

Authors:  Hannes Hagström
Journal:  Curr Hepatol Rep       Date:  2017-04-22

4.  Association of alcohol consumption with prevalence of fatty liver after adjustment for dietary patterns: Cross-sectional analysis of Japanese middle-aged adults.

Authors:  Ryoko Tajima; Fumiaki Imamura; Takeshi Kimura; Satomi Kobayashi; Katsunori Masuda; Kaoruko Iida
Journal:  Clin Nutr       Date:  2019-07-26       Impact factor: 7.324

Review 5.  Ethnicity matters: A Systematic Review and Meta-Analysis of the Non-Linear Relationship Between Alcohol Consumption and Prevalence and Incidence of Hepatic Steatosis.

Authors:  Michael Roerecke; Radu Nanau; Jürgen Rehm; Manuela Neuman
Journal:  EBioMedicine       Date:  2016-04-20       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.